World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
70230
World Ranking
5051
National Ranking
138

Overview

Sunil R. Lakhani is affiliated with the University of Queensland in Australia and has made significant contributions in the fields of medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on cancer-related studies, particularly in oncology, molecular biology, and cancer research as well as pulmonary and respiratory medicine and pathology and forensic medicine.

The main topics of their research include:

  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Brain Metastases and Treatment
  • Cancer Immunotherapy and Biomarkers
  • BRCA gene mutations in cancer
  • Cancer Cells and Metastasis

Frequent publication venues for Sunil R. Lakhani's work comprise:

  • Histopathology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cancers
  • Journal of Clinical Oncology
  • Annals of Oncology

The scientist often collaborates with several co-authors, including:

  • Amy E. McCart Reed
  • Peter T. Simpson
  • Jodi M. Saunus
  • Kaltin Ferguson
  • Jamie R. Kutasovic

Recent notable publications by Sunil R. Lakhani include:

  • Adjuvant Olaparib for Patients with BRCA1 - or BRCA2 -Mutated Breast Cancer, 2021, New England Journal of Medicine
  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update, 2020, Journal of Clinical Oncology
  • The 2019 World Health Organization classification of tumours of the breast, 2020, Histopathology
  • Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer, 2022, Annals of Oncology
  • Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update, 2020, Archives of Pathology & Laboratory Medicine

Best Publications

  • Signatures of mutational processes in human cancer

    Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • WHO classification of tumours of the breast

    Sunil R. Lakhani;Ian O. Ellis;Stuart J. Schnitt;Puay Hoon Tan

  • Landscape of somatic mutations in 560 breast cancer whole-genome sequences

    Serena Nik-Zainal;Serena Nik-Zainal;Helen Davies;Johan Staaf;Manasa Ramakrishna

  • The landscape of cancer genes and mutational processes in breast cancer

    Philip J. Stephens;Patrick S. Tarpey;Helen Davies;Peter Van Loo;Peter Van Loo

  • Association analysis identifies 65 new breast cancer risk loci

    Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley

  • Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).

    M O Leach;C R M Boggis;A K Dixon;D F Easton

  • The Pathology of Familial Breast Cancer: Predictive Value of Immunohistochemical Markers Estrogen Receptor, Progesterone Receptor, HER-2, and p53 in Patients With Mutations in BRCA1 and BRCA2

    Sunil R. Lakhani;Marc J. van de Vijver;Jocelyne Jacquemier;Thomas J. Anderson

  • Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth

    Lin Zhang;Siyuan Zhang;Siyuan Zhang;Jun Yao;Frank J. Lowery

  • Breast cancer prognostic classification in the molecular era: the role of histological grade

    Emad A. Rakha;Jorge S. Reis-Filho;Frederick Baehner;David J. Dabbs

  • Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

    Andrew N.J. Tutt;Judy E. Garber;Bella Kaufman;Giuseppe Viale

  • Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update.

    Kimberly H. Allison;M. Elizabeth H. Hammond;Mitchell Dowsett;Shannon E. McKernin

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

    Helen Davies;Dominik D. Glodzik;Sandro S. Morganella;Lucy R. Yates

  • Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group Part 2 TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Shona Hendry;Roberto Salgado;Thomas Gevaert;Prudence A. Russell;Prudence A. Russell

  • Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

    Sunil Badve;David J. Dabbs;Stuart J. Schnitt;Frederick L. Baehner

  • Identification of the familial cylindromatosis tumour-suppressor gene.

    Graham R. Bignell;William Warren;Sheila Seal;Meiko Takahashi

  • Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 Mutations

    Sunil R. Lakhani;Jocelyne Jacquemier;John P Sloane;Barry A. Gusterson

  • Prediction of BRCA1 Status in Patients with Breast Cancer Using Estrogen Receptor and Basal Phenotype

    Sunil R. Lakhani;Jorge S. Reis-Filho;Laura Fulford;Frederique Penault-Llorca

  • Molecular evolution of breast cancer

    Peter T Simpson;Jorge S Reis-Filho;Jorge S Reis-Filho;Jorge S Reis-Filho;Theodora Gale;Sunil R Lakhani

Frequent Co-Authors

Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Stephen B. Fox
Stephen B. Fox Peter MacCallum Cancer Centre
Michael R. Stratton
Michael R. Stratton Wellcome Sanger Institute
Kum Kum Khanna
Kum Kum Khanna Mater Research
Nicola Waddell
Nicola Waddell QIMR Berghofer Medical Research Institute
Andrea L. Richardson
Andrea L. Richardson Johns Hopkins University
Chris Jones
Chris Jones Institute of Cancer Research
Serena Nik-Zainal
Serena Nik-Zainal University of Cambridge
Anne Lise Børresen-Dale
Anne Lise Børresen-Dale Oslo University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related healthcare degrees online can open a variety of career pathways beyond traditional medical school. For those aiming to advance nursing practice with flexibility and affordability, check out cheap dnp online programs. These programs are ideal for nurses who want to move into leadership or specialized clinical roles.

If you’re interested in medication management and pharmaceutical care, consider researching pharmacy school online. Online pharmacy doctorates can help students balance work, family, and education, while preparing for pharmacist licensure exams.

For those drawn to healthcare IT and data management, earning an him bachelor's degree online is a smart choice. This pathway prepares graduates to handle sensitive medical data and support quality patient care in a digital age.

Another fast-growing field is medical administration. Prospective students frequently ask how much is medical billing and coding school. Online courses in this area are often affordable and offer a quick route into healthcare without extensive clinical training.

Best Scientists Citing Sunil R. Lakhani

Trending Scientists